Parallel Advisors’s Surmodics SRDX Stock Holding History

Parallel Advisors’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-35	Closed	-$1.05K	–	3747
2025 Q3	$1.05K	Hold	35	–	–	﹤0.01%	3208
2025 Q2	$1.04K	Sell	35 -4	-10%	-$115	﹤0.01%	3187
2025 Q1	$1.19K	Sell	39 -173	-82%	-$5.83K	﹤0.01%	3085
2024 Q4	$8.39K	Hold	212	–	–	﹤0.01%	2467
2024 Q3	$8.22K	Hold	212	–	–	﹤0.01%	2468
2024 Q2	$8.91K	Buy	+212	New	+$7.23K	﹤0.01%	2360
2022 Q3	–	Sell	-217	Closed	-$8K	–	3480
2022 Q2	$8K	Buy	+217	New	+$8.42K	﹤0.01%	2096

Other funds holding SRDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Parallel Advisors's SRDX Position: Q4 2025 in Review

Parallel Advisors sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 35 shares — an estimated $1.05K sold.

Parallel Advisors first reported a position in SRDX in Q2 2022 and held it in 7 quarters. The position peaked at $8.91K in Q2 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

Parallel Advisors reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
Parallel Advisors sold 35 Surmodics shares in Q4 2025, an estimated $1.05K.
Parallel Advisors first reported a position in Surmodics in Q2 2022 and held it in 7 quarters.
Parallel Advisors's Surmodics position peaked at $8.91K in Q2 2024.
1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Parallel Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.